News

Altimmune: Potential Tough Road Ahead Amid Fierce Competition (Rating Downgrade)
Altimmune's pemvidutide showed strong MASH resolution and good tolerability in IMPACT, but fibrosis data fell short. See why ...
KTEN5d
Stocks consolidate after bumper week buoyed by resilient US economy
US and European stock markets stalled or trimmed gains on Friday after a bullish week buoyed by US data and upbeat company ...
BofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510
GSK plc (NYSE:GSK) is one of the best cheap stocks under $50 to buy now. On July 15, BofA analyst Sachin Jain maintained a ...
CNBCTV186d
Stock Market Highlight: Nifty 50 below 25,000, Sensex falls 502 points as financials drag
The Sensex dropped 502 points on Friday to close at 81,758, while the Nifty slipped 143 points to end below the 25,000 mark ...
GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt
GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...